A Day Up For RAPT Therapeutics, Inc.
Fri, May 23, 2025 at 07:37 PM
RAPT Therapeutics, Inc. (RAPT:NASDAQ) shot up at $1.23, representing a gain of 43.3%. On Fri, May 23, 2025, RAPT:NASDAQ hit a New 2-Week High of $1.23. The stock appeared on our News Catalysts scanner on Sat, May 10, 2025 at 10:04 PM in the 'EARNINGS' category. From Fri, May 09, 2025, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Mar 25, 2025 at $1.57 with a volume of 1M+.
About RAPT Therapeutics, Inc. (RAPT:NASDAQ)
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 9900.02%
- Imunon, Inc. (IMNN:NASDAQ), 179.18%
- F45 Training Holdings Inc. (FXLV:NYSE), 98.68%
- SharpLink Gaming, Inc. (SBET:NASDAQ), 78.72%
- Powell Max Limited (PMAX:NASDAQ), 57.38%
- BloomZ Inc. (BLMZ:NASDAQ), 56.72%
- RAPT Therapeutics, Inc. (RAPT:NASDAQ), 43.34%
- Lightbridge Corporation (LTBR:NASDAQ), 42.59%
- Douglas Elliman Inc. (DOUG:NYSE), 35.51%
- INNEOVA Holdings Limited (INEO:NASDAQ), 35.21%